Cellular Logistics’ Tandem HF technology, discovered by chief science officer Eric Schmuck in the research labs of cardiologist Amish Raval at the UW-Madison, is based on combining a framework of proteins derived from cardiac fibroblasts — a certain type of heart cell — with cardiomyocytes, or heart muscle stem cells.